Details Cookies
Cookie Policy

This website uses cookies to offer you a better browsing experience by enabling, optimising and analysing site operations, as well as to provide personalised ad content and allow you to connect to social media. By choosing “Accept all” you consent to the use of cookies and the related processing of personal data. Select “Manage consent” to manage your consent preferences. You can change your preferences or retract your consent at any time via the cookie policy page. Please view our cookie policy here and our privacy policy here

Market Quick Take - October 2, 2020 Market Quick Take - October 2, 2020 Market Quick Take - October 2, 2020

Market Quick Take - October 2, 2020

John Hardy

Head of FX Strategy

Summary:  The US equity market tried to hold on to its recent gains despite the lack of progress on US stimulus talks, but the futures stumbled badly this morning on the news that US President Trump and his wife both tested positive for Covid-19 after traveling with an aide that later tested positive. The US dollar firmed slightly overnight and then further on the Trump news.

What is our trading focus?

  • S&P 500 Index (US500.I) & NASDAQ 100 Index (USNAS100.I) – US equities traded to new highs yesterday despite lack of progress on US stimulus (more on that below) and Trump’s quarantining, with local resistance above 11,500 taken out in the Nasdaq-100, leaving only the 11,750 area 61.8% Fibo as the last major resistance ahead of the all-time highs. Early morning here in Europe news has broken that Trump has also tested positive for Covid-19 immediately taking down US equity futures with the Nasdaq 100 futures breaking below yesterday’s open and back into the previous trading range.

  • STOXX 50 Index (EU50.I) – European equities are reacting to the news about US president Donald Trump has tested positive for Covid-19 but to the same degree as US equity futures. The first major key support level is at 3,136 and then 3,319. If these levels cannot hold today it opens for further declines in the short-term. We expect high beta sectors such as financials and consumer discretionary to lead the decline on the open.

  • Long volatility (VOOL:xetr) - with the muted response in gold and US Treasuries it is getting obvious that long volatility component will begin to play a crucial part of controlling risk in portfolio and asset allocation strategies. VIX futures are touching 34 this morning up more than 3 points suggesting a big move in long volatility structures such as Long short-term VIX futures.

  • EURUSD and AUDUSD - the US dollar was taken all the way to the brink of important local support before finding its legs again. With the rally overnight away from this support on US stimulus doubts and now Trump’s positive Covid-19 test, the final local support line is now somewhat clearer in EURUSD in yesterday’s 1.1765+ high and likewise, the 0.7200+ high in AUDUSD yesterday. Ahead of the weekend, the US dollar is likely to trade very reflexively with negative correlation to risk sentiment.

  • EURGBP and GBPUSD – severe back and forth in sterling pairs yesterday as headlines touted the lack of sufficient progress in Brexit talks to achieve what some call the “landing zone” or the “tunnel”, which basically means that there is a strong enough agreement in principle for to the two sides to hunker down and hammer out the details of a post-Brexit transition deal over the coming weeks. The headline risk is extreme and traders are advised to consider limited-risk options strategies (long puts and calls or put- or call- spreads) to express a view over the next two weeks to 1-month (the horizon over which it could become clear that a deal is a go or a no-go and/or beyond the December 31 end date of the transition period.

  • Spot Gold (XAUUSD) and Spot Silver (XAGUSD) - overnight weakness in both metals on U.S. stimulus impasse turned to strength following the White House announcement that Trump and FLOTUS had both tested positive. Gold has now despite the stronger dollar returned above $1900 with its relative strength most visible against other currencies. The market will be trading nervous today as we have seen the virus can have many faces, from a Boris Johnson critical one to others who sailed through relatively unharmed. Overall, however this is not an event that leads to gold selling. Next up, monthly US job report and the U.S. stimulus impasse.

  • WTI Crude Oil (OILUSNOV20) & Brent Crude Oil (OILUKNOV20) - extended yesterday’s losses on the Trump news and after chances of a U.S. fiscal stimulus package before the election faded. Overall the market has held up well during the past couple of weeks while the short-term fundamental outlook has weakened with the global energy demand recovery stalling amid rising Covid-19 cases around the world. Having failed to challenge resistance above $42.60/b, Brent crude is once again testing support at $39.50/b with the next level being $37/b.

What is going on?

  • US President Trump and First Lady Melania Trump tested positive for Covid-19. The news broke overnight that Trump aide Hope Hicks test positive after she traveled with Trump aboard Air Force One on Tuesday and Wednesday to election rallies before feeling ill and self-quarantining on the plane on the return flight. The positive test result was announced by Trump himself this morning in early European hours.

  • US House Democrats pass their $2.2 trillion stimulus plan with no Republican support - even as House Speaker Pelosi said negotiations with the White House would continue. Key points of contention include aide for local and state governments, with the White House not wanting to support what it sees as mismanaged Democratic strongholds. Time is running out for a deal with just over a month to the November 3rd election and Congress in recess soon to make room for election campaigning.

  • US data was a mixed bag – with the weekly initial jobless claims still at a very elevated 837k, although this was slightly better than expected and the lowest weekly tally since the crisis began for the US economy. Better news was the weekly continuing claims data, which dropped by 1 million from its upwardly revised number and now stands below 12 million. The Sep. ISM Manufacturing number, meanwhile surprised slightly to the downside with a reading of 55.4 vs. 56.5 expected and 56.0 in Augusts. The employment sub-component was still below 50, even if the 49.2 reading was the highest in over a year.

  • Eurocoin GDP growth indicator rose in September first positive change since February’s reading suggesting that Europe’s economy is turning around. Even more positively it happens at a time with a resurgence in Covid-19 cases. If economic activity continues to improve the next couple of months, then this could turn into that positive narrative that Europe has lacked.

  • New York City and State rating downgraded by Moody’s. The rating agency has downgraded bond rating for NY city and state to Aa2 from Aa1. The average 10 year spread of its debt versus a AAA rated state debt widened 55bps since the beginning of the year, making it more expenses for the state and municipality to raise capital.

What we are watching next?

  • Progress on Trump’s Covid-19 recovery – markets will be tiptoeing on news about Trump’s recovery with potential downward moves linked to adverse developments such as those that happened to the UK PM Boris Johnson when he fell ill with Covid-19.

  • Ant Group IPO – one the biggest IPOs in history is still pending with expected offering size at this point of $6.94bn. There is still no announced pricing date, but we expect it to be imminent.

Economic Calendar Highlights for today (times GMT)

  • 0800 – Norway Sep. Unemployment Rate
  • 0900 – Eurozone Sep. (P) CPI
  • 1230 – US Sep. Nonfarm Payrolls & Hourly Earnings
  • 1230 – US Sep. Unemployment Rate
  • 1400 – US Aug. Factory Orders
  • 1400 – US Final Sep. University of Michigan Sentiment

Follow SaxoStrats on the daily Saxo Markets Call on your favorite podcast app:

Apple Sportify Soundcloud Stitcher


Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (
- Analysis Disclaimer (
- Notification on Non-Independent Investment Research (

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.